Inhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro

Journal of Surgical Research

Volumn 177, Issue 2, 2012, Pages 255-262

  Kostin, Shannon F ^a   McDonald, Debbie E ^a   McFadden, David W ^a,b,c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

( ) Epigallocatechin 3 gallate; Antioxidants; Apoptosis; Cell cycle; Cell proliferation; Cytochrome C; Mitochondrial depolarization; Natural compounds; Pancreatic cancer; Pterostilbene

Indexed keywords

ANTIOXIDANT; CASPASE 3; CASPASE 7; EPIGALLOCATECHIN GALLATE; PTEROSTILBENE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLUEBERRY; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DEPOLARIZATION; DRUG POTENTIATION; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; PANCREAS CANCER; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; CARCINOMA; CASPASES; CATECHIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROMES C; DNA FRAGMENTATION; DRUG EVALUATION, PRECLINICAL; HUMANS; PANCREATIC NEOPLASMS; STILBENES;

EID: 84866026048     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.04.023     Document Type: Article

References (25)

1. A. Jemal, R. Siegel, and J.Q. Xu Cancer statistics, 2010 CA Cancer J Clin 60 2010 277
2. B. McMillan, D.R. Riggs, and B.J. Jackson Dietary influence on pancreatic cancer growth by catechin and inositol hexaphosphate J Surg Res 141 2007 115
3. Y. Li, T. Zhang, and Y. Jiang (-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line MIA PACA-2 Mol Pharm 6 2009 1152
4. K. Pliarchopoulou, and D. Pectasides Pancreatic cancer: Current and future treatment strategies Cancer Treat Rev 35 2009 431
5. J.G. Schneider, J.A. Alosi, and D.E. McDonald Effects of pterostilbene on melanoma alone and in synergy with inositol hexaphosphate Am J Surg 198 2009 679
6. P.W. Mannal, J.A. Alosi, and J.G. Schneider Pterostilbene inhibits pancreatic cancer in vitro J Gastrointest Surg 14 2010 873
7. H.H. Chow, Y. Cai, and I.A. Hakim Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals Clin Cancer Res 9 2003 3312
8. M.A. Shammas, P. Neri, and H. Koley Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: Biologic activity and therapeutic implications Blood 108 2006 2804
9. M. Sukhthankar, K. Yamaguchi, and S.H. Lee A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer Gastroenterology 134 2008 1972
10. J.E. Pizzorno Jr., and M.T. Murra y Textbook of Natural Medicine 2006 Churchill Livingstone Elsevier Maryland Heights, MO
11. J.A. Alosi, D.E. McDonald, and J.S. Schneider Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis J Surg Res 161 2010 195
12. S. Shankar, G. Suthakar, and R.K. Srivastava Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer Front Biosci 12 2007 5039
13. M. Takada, Y. Nakamura, and T. Koizumi Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate Pancreas 25 2002 45
14. H.A. Vu, Y. Beppu, and H.T. Chi Green tea epigallocatechin gallate exhibits anticancer effect in human pancreatic carcinoma cells via the inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor J Biomed Biotechnol 2010 2010 290516
15. McCormack DE, Mannal P, McDonald D, et al. Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivo. J Gastrointest Surg Epub 2012 Mar 27.
16. P. Wang, S.M. Henning, and D. Heber Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols PLoS One 5 2010 e10202
17. S. Qanungo, M. Das, and S. Haldar Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells Carcinogenesis 26 2005 958
18. M.H. Pan, Y.H. Chang, and V. Badmaev Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells J Agric Food Chem 55 2007 7777
19. S. Shankar, S. Ganapathy, and S.R. Hingorani EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer Front Biosci 13 2008 440
20. J.F. Lyons, S. Wilhelm, and B. Hibner Discovery of a novel Raf kinase inhibitor Endocr Relat Cancer 8 2001 219
21. M. Goggins, S.E. Kern, and J.A. Offerhaus Progress in cancer genetics: Lessons from pancreatic cancer Ann Oncol 10 Suppl 4 1999 4
22. A. Scholz, S. Heinze, and K.M. Detjen Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer Gastroenterology 125 2003 891
23. P.S. Moore, B. Sipos, and S. Orlandini Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4 Virchows Arch 439 2001 798
24. I.M. Kapetanovic, M. Muzzio, and Z. Huang Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats Cancer Chemother Pharmacol 68 2011 593
25. H.H. Chow, Y. Cai, and D.S. Alberts Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E Cancer Epidemiol Biomarkers Prev 10 2001 53